Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.375NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.375NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BL.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AD.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-16197.2US
AD.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AD.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-16933China
XBB.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.26.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.26.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.26.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.10.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.10.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.10.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBTNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBTNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBTNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.33NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CL.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CL.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CL.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BM.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BM.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBMNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used